Press release
Compounding Pharmacy Market worth $19.41 billion by 2030 with 5.7% CAGR | MarketsandMarkets Trademark
The Asia-Pacific region is emerging as the fastest-growing market in the global compounding pharmacy sector, driven by rising healthcare awareness, increasing prevalence of chronic and complex diseases, and expanding demand for personalized medications.
The global Compounding Pharmacy Market [https://www.marketsandmarkets.com/Market-Reports/compounding-pharmacy-market-57885999.html?utm_source=abnewswire.com&utm_medium=paidpr&utm_campaign=compoundingpharmacymarket], valued at US$13.48 billion in 2024, stood at US$14.72 billion in 2025 and is projected to advance at a resilient CAGR of 5.7% from 2025 to 2030, culminating in a forecasted valuation of US$19.41 billion by the end of the period. The market growth can be credited to persistent drug shortages in North America and Europe and the continued demand-supply gap for GLP-1 drugs.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=57885999 [https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=57885999&utm_source=abnewswire.com&utm_medium=paidpr&utm_campaign=compoundingpharmacymarket]
By product, the global compounding pharmacy market is divided into seven main categories based on product type: topical drugs, oral drugs, parenteral drugs, rectal drugs, nasal drugs, ophthalmic drugs, and other products. The oral drugs segment holds the largest share in the market, driven by the demand for customized, patient-specific therapies that meet individual medical needs. Oral formulations such as capsules, tablets, suspensions, and solutions are widely used across various therapeutic areas, including hormone replacement, pediatric and geriatric care, pain management, gastrointestinal disorders, and chronic disease management. The ability to customize dosage strengths, flavors, excipients, and release profiles improves patient adherence, especially for populations with difficulty swallowing tablets or needing precise dose adjustments. The rising prevalence of chronic diseases like diabetes, cardiovascular conditions, and endocrine disorders further increases the demand for personalized oral medications that can enhance efficacy while reducing side effects. Advances in formulation technologies-including sustained-release systems, taste-masking techniques, and bioavailability-enhancing carriers-improve therapeutic results and patient satisfaction. Compliance with FDA guidelines and USP standards ensures that compounded oral medications meet strict safety, sterility, and quality requirements, building trust among healthcare providers. Moreover, increasing awareness of personalized medicine and broader access through hospital, specialty, and retail compounding pharmacies support the segment's growth. With the merging of patient-focused care, technological progress, and rising demand for convenient, customizable oral therapies, the oral drugs segment continues to significantly contribute to revenue growth and innovation in the global compounding pharmacy industry.
By application, Hormone replacement therapy (HRT) is emerging as the fastest-growing segment in the compounding pharmacy market, driven by increasing awareness of personalized treatment options for hormonal imbalances and age-related conditions. Compounded HRT allows customization of hormone type, dosage, and delivery method, such as creams, gels, troches, or injections, tailored to individual patient needs, enhancing efficacy and minimizing side effects compared to standard commercially available therapies. The rising prevalence of menopause-related symptoms, andropause, and other endocrine disorders has fueled demand for individualized therapies that address unique hormonal profiles. Advances in formulation technologies, including bioidentical hormones and transdermal delivery systems, have improved absorption, stability, and patient compliance. The trend toward patient-centric care, combined with healthcare provider preference for personalized dosing, positions HRT as a key driver of growth within the therapeutic segment. Regulatory oversight by the FDA and adherence to USP standards ensure the safety and quality of compounded hormone therapies, further bolstering confidence. Expanding access through specialty and retail pharmacies, coupled with ongoing research on long-term efficacy and safety, reinforces hormone replacement therapy's role as the fastest-growing application in the global compounding pharmacy market.
By geography, the market for compounding pharmacy is divided into five segments: North America, Europe, the Asia Pacific, Latin America, the Middle East & Africa. The Asia-Pacific region is emerging as the fastest-growing market in the global compounding pharmacy sector, driven by rising healthcare awareness, increasing prevalence of chronic and complex diseases, and expanding demand for personalized medications. Rapid urbanization, growing disposable incomes, and better access to healthcare facilities are fueling the adoption of compounded therapies, especially in countries like China, India, Japan, and Australia. The region benefits from a rising number of hospital pharmacies, specialty clinics, and compounding service providers offering customized dosage forms, including sterile preparations, topical drugs, and hormone replacement therapies. Government initiatives to improve healthcare infrastructure, along with increased regulatory focus on quality standards and patient safety, are encouraging market growth. Advances in compounding technologies, such as automated sterile preparation systems and digital workflow solutions, further improve efficiency and product consistency. Additionally, growing awareness of patient-centered care, non-invasive therapies, and pediatric and geriatric treatment needs supports the adoption of compounded medications. These factors collectively position Asia-Pacific as the fastest-growing regional market, creating significant opportunities for both established players and new entrant pharmacies.
Request Sample Pages : https://www.marketsandmarkets.com/requestsampleNew.asp?id=57885999 [https://www.marketsandmarkets.com/requestsampleNew.asp?id=57885999&utm_source=abnewswire.com&utm_medium=paidpr&utm_campaign=compoundingpharmacymarket]
Key players in the compounding pharmacy market include Baxter (US), Empower Pharmacy (US), B. Braun (Germany), Fagron (Netherlands), QuVa Pharma (US), SCA Pharma (US), Nephron Pharmaceuticals (US), Leiters Health (US), Pharmaxo (UK).
Baxter (US):
Baxter (US) is a leading player in the compounding pharmacy market, offering a broad range of sterile and non-sterile compounding services with a strong presence in developed and emerging markets. The company's extensive expertise and comprehensive service portfolio have helped it gain a significant market share and establish itself as a dependable partner in biopharmaceutical manufacturing. Baxter also emphasizes inorganic growth strategies, such as acquisitions and strategic partnerships, to expand its capabilities and global presence.
Empower Pharmacy (US)
Empower Pharmacy (US) is a leading compounding pharmacy that specializes in customized medications, including sterile and non-sterile formulations, tailored to meet individual patient needs. The company operates one of the largest and most advanced 503A and 503B compounding facilities in the US, ensuring high-quality, compliant, and scalable production. Empower Pharmacy serves healthcare providers, clinics, and hospitals nationwide, focusing on innovation, regulatory excellence, and patient-centered care. The company continues to grow its capabilities and market presence through infrastructure investments and technology-driven compounding solutions.
Media Contact
Company Name: MarketsandMarkets Trademark Research Private Ltd.
Contact Person: Mr. Rohan Salgarkar
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=compounding-pharmacy-market-worth-1941-billion-by-2030-with-57-cagr-marketsandmarkets]
Phone: 18886006441
Address:1615 South Congress Ave. Suite 103, Delray Beach, FL 33445
City: Florida
State: Florida
Country: United States
Website: https://www.marketsandmarkets.com/Market-Reports/compounding-pharmacy-market-57885999.html
Legal Disclaimer: Information contained on this page is provided by an independent third-party content provider. ABNewswire makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact retract@swscontact.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Compounding Pharmacy Market worth $19.41 billion by 2030 with 5.7% CAGR | MarketsandMarkets Trademark here
News-ID: 4271941 • Views: …
More Releases from ABNewswire
The Boulder Group Arranges Sale of Net Leased North Carolina Walgreens
The Boulder Group, a net leased investment brokerage firm completed the sale of a single tenant Walgreens located at 219 Rodney Orr Bypass in Robbinsville, North Carolina for $2,875,000.
The 9,665-square-foot building is strategically located along Rodney Orr Bypass, the primary thoroughfare in Robbinsville, which sees over 10,000 vehicles per day. The property is surrounded by major retailers, including Ace Hardware, McDonald's, Wendy's, Carquest, and Dollar General, all of which generate…
Gold Prices Are Rising Again - Gilbert Gold Buyers Encourages Arizona Residents …
With gold prices rising, Gilbert Gold Buyers urges residents in Gilbert, Mesa, Chandler, and Tempe to sell unwanted gold and silver. The trusted Arizona gold dealer pays top dollar - no amount too small.
As gold prices surge once again, Gilbert Gold Buyers, a trusted and established gold dealer in Gilbert, Arizona, is encouraging residents throughout the East Valley to take advantage of the rising market. With values climbing and buyer…
Nouvelle Towns Launches in Oshawa, Offering Attainable Entry Into First-Time Hom …
Boutique 26-suite townhome community in Oshawa offers attainable first-time ownership and wealth-building.
Image: https://www.abnewswire.com/upload/2025/12/f1bbe2ebd72604b777c34571e5bf3779.jpg
Oshawa, Ontario - In a market where many first-time buyers feel shut out, Build Up Development Co. is redefining the entry point to homeownership with the launch of Nouvelle Towns, a 27-suite modern townhome community in North Oshawa. The project emphasizes long-term wealth-building potential through homeownership, placing first-time buyers on a path toward generational wealth.
Your first home isn't…
Ecuadorian Rainforest Joins the Organic Trade Association at Food Ingredients Eu …
The company highlights the strength of the U.S. organic sector while connecting with global buyers in Paris.
Image: https://www.abnewswire.com/upload/2025/12/c03e2070716870008c105c5ebccafded.jpg
Clifton, NJ - Ecuadorian Rainforest, LLC participated alongside the Organic Trade Association (OTA) at Food Ingredients Europe 2025 in Paris, France. The event brought together international food and nutrition professionals, offering a valuable platform for showcasing the depth and quality of U.S. organic ingredients.
The company reported a successful show, noting strong interest in…
More Releases for Pharma
Miglitol Market Size, Share and Forecast By Key Players-Weiao Pharma, Zhejiang M …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Miglitol market is anticipated to grow at a compound annual growth rate (CAGR) of 11.49% between 2024 and 2031. The market is expected to grow to USD 22.32 Billion by 2024. The valuation is expected to reach USD 47.79 Billion by 2031.
The Miglitol market is experiencing significant growth due to the rising prevalence of diabetes and the increasing awareness of the…
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031.
The Dacarbazine market is projected to witness significant growth in the coming years, driven by increasing…
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031.
The dacarbazine market is experiencing steady growth, driven by the rising incidence of cancer globally. As…
Epilepsy Pipeline Assessment 2024: Therapies, Clinical Trials, and Market Insigh …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Epilepsy pipeline constitutes 75+ key companies continuously working towards developing 90+ Epilepsy treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.
The Epilepsy Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed description of the…
Global Indomethacin Market Seeking Excellent Growth by 2028 | Ratiopharm, Merck, …
"IBI has published a report entitled Global Indomethacin Market Research Report which provides comprehensive data on emerging trends, market drivers, growth opportunities, and barriers that could change the dynamics of the industry market. It provides an in-depth analysis of market segments which includes the product, application, and competitor analysis.
Click Here To Order A Sample Copy Of Indomethacin Global Market Report : https://www.infinitybusinessinsights.com/request_sample.php?id=380382
The Indomethacin Global Market Research Report provides close monitoring…
Roxatidine Market 2020: Top Companies Analysis To Grow Healthcare Business by 20 …
Business Industry Reports Research has recently announced a report on Global Roxatidine Market based on the Category Industry. The Roxatidine Market report emphasizes various key aspects, which include growth drivers, restraints, opportunities and recent market trends for the forecast period 2020-2024.
Global Roxatidine Market overview:
Business Industry Reports Analyst covers the Major Players data, including: shipment, revenue, gross profit, interview record, business distribution etc., these data help the consumer know about the…
